Moreover, we also investigated the correlation between IL20RB and genes involved in immunotherapy, including PDCD-1, CTLA4, LAG3 and HAVCR2.The result showed that IL20RB expression was associated significantly with these immune checkpoints, suggesting that IL20RB was a potential therapeutic target correlated with tumor immunology. This evidence concerns the gene IL20RB and neoplasm.